Designing clinical and genetic guidelines of colorectal cancer screening as an effective roadmap for risk management
Gastroenterology and Hepatology from Bed to Bench,
Vol. 9 No. Supplement 1 (2016),
8 December 2016
https://doi.org/10.22037/ghfbb.v0i0.967
Abstract
Aim: We aimed to present clinical and genetic guidelines of colorectal cancer screening for risk assessment of populations at risk. Background: National guidelines can be used as a guide for choosing the method of screening for each individual. These guidelines facilitate decision making and support the delivery of cancer screening service.
Methods: In the first step, a comparative study was performed by using secondary data extracted from the literature review. Three countries (Canada, Australia and United States) were selected from 25 countries that are member in the International Cancer Screening Network (ICSN). The second step of study was qualitative survey. The study was based on the grounded theory approach. Study tool was semi-structured interview. Interviewing involves asking questions and getting answers from participants. 22 expert’s perspectives about guidelines of colorectal cancer screening were surveyed.
Results: Screening program of selected countries was compared. Countries were surveyed by number of risk groups and subgroups, criteria for risk assessment, beginning age, recommendations, screening approaches and intervals. Australia and United States have three risk groups and Canada has two risk groups. Four risk groups were defined in the national guideline, including high risk, increased risk, average and low risk group. The high risk group comprises of 8 subgroups, increased risk group comprises of 3 subgroups and average risk group contain 4 subgroups. Approved clinical criteria for hereditary syndromes and the roadmap of genetic and pathologic survey were designed. Conclusions: Guidelines and pathways have a vital role in the quality improvement of CRC screening program. National guidelines were refined according to the environmental and genetic criteria of colorectal cancer in Iran. These guidelines provide evidence-based recommendations by risk groups. National pathways as a risk assessment tool can evaluate and improve the processes and outcomes of cancer screening in practice. One of the suggestions for future research is the designing expert system for real-time decision making during a clinical interaction.
- Colorectal Cancer
- Screening
- Guideline
How to Cite
References
References
- Pan J, Xin L, Ma YF, Hu LH, Li ZS.Colonoscopy Reduces Colorectal Cancer Incidence and Mortality in Patients With Non-Malignant Findings: A Meta-Analysis. Am J Gastroenterol. 2016 Mar;111(3):355-65.
- Gooran Navid, Aminsharifi Shima, Maserat Elham, Soltani Masoume, Fatemi Seyed Reza. The role of information systems in cancer prevention. Gastroenterology and Hepatology From Bed to Bench 2010;3(4):164-168.
- Lieberman DA, Rex DK, Winawer SJ, Giardiello FM, Johnson DA, et al. Guidelines for colonoscopy surveillance after screening and polypectomy: a consensus update by the US Multi-Society Task Force on Colorectal Cancer. Gastroenterology. 2012 Sep;143(3):844-57.
- Järvinen HJ, Aarnio M, Mustonen H, Aktan-Collan K, Aaltonen LA. Controlled 15-year trial on screening for colorectal cancer in families with hereditary nonpolyposis colorectal cancer. Gastroenterology. 2000 May;118(5):829-34.
- Watanabe T, Itabashi M, Shimada Y, Tanaka S, Ito Y,et al. Japanese Society for Cancer of the Colon and Rectum (JSCCR) Guidelines 2014 for treatment of colorectal cancer. Int J Clin Oncol. 2015; 20(2): 207–239.
- Hoyt David B. Clinical practice guidelines. American Journal of Surgery.1997;173(1): 32-34.
- Pan J, Xin L, Ma YF, Hu LH, Li ZS. Colonoscopy Reduces Colorectal Cancer Incidence and Mortality in Patients With Non-Malignant Findings: A Meta-Analysis. Am J Gastroenterol. 2016 Mar;111(3):355-65.
- Aldredge Wayne . Clinical practice guidelines. 2016 June; 147(6): 388–389.
- Sohal DP, Mangu PB, Khorana AA, Shah MA, Philip PA. Metastatic Pancreatic Cancer: American Society of Clinical Oncology Clinical Practice Guideline. J Clin Oncol. 2016 May 31.
- Levin B, Lieberman DA, McFarland B, Andrews KS, Brooks D, Bond J, Dash C, Giardiello FM, Glick S, Johnson D, Johnson CD, Levin TR, Pickhardt PJ, Rex DK, Smith RA, Thorson A, Winawer SJ. Screening and Surveillance for the Early Detection of Colorectal Cancer and Adenomatous Polyps: A Joint Guideline From the American Cancer Society, the US Multi-Society Task Force on Colorectal Cancer, and the American College of Radiology. Gastroenterology 2008; 134: 1570-1595.
- Heselmans A, Van de Velde S, Donceel P, Aertgeerts B, Ramaekers D. Effectiveness of electronic guideline-based implementation systems in ambulatory care settings - a systematic review. Implement Sci. 2009 Dec 30;4:82.
- Javan Amoli AH, Maserat E, Safdari R, Zali MR. Electronic Risk Assessment System as an Appropriate Tool for the Prevention of Cancer: a Qualitative Study. Asian Pac J Cancer Prev. 2015;16(18):8595-8.
- Jimbo Masahito, Gurpreet K. Rana , Sarah Hawley, Margaret Holmes-Rovner, Karen Kelly-Blake, et al. What is lacking in current decision aids on cancer screening? .CA Cancer J Clin. 2013 May; 63(3): 193–214.
- Courtney Ryan J , Email author, Christine L Paul, Robert W Sanson-Fisher, Finlay A Macrae, et al. Colorectal cancer risk assessment and screening recommendation: a community survey of healthcare providers' practice from a patient perspective.BMC Family Practice. 2012;13(17).
- Tyler CV, Synder CW: Cancer risk assessment: Examining the family physician's role. J Am Board Fam Med. 2006; 19: 468-477.
- Flynn BS, Wood ME, Ashikaga T, Stockdale A, Dana GS, Naud S. Primary care physicians' use of family history for cancer risk assessment. BMC Family Practice.2010; 11: 45-10.
- Fry A, Campbell H, Gudmundsdottir H, Rush R, Porteous M,et al. GP's view on their role in cancer genetics services and current practice. Fam Pract. 1999; 16: 468-474.
- Suther S, Goodson P. Barriers to the provision of genetic services by primary care physicians: a systematic review of the literature. Genet Med. 2003, 5: 70-76.
- American cancer society. Colorectal cancer risk factors. Retrieved Jun 1, 2016 from http://www.cancer.org/cancer/colonandrectumcancer/detailedguide/colorectal-cancer-risk-factors
- Myers RE, Weinberg DS, Manne SL, Sifri R, Cocroft J, et al. Genetic and environmental risk assessment for colorectal cancer risk in primary care practice settings: a pilot study. Genet Med. 2007 Jun;9(6):378-84.
- Wood ME, Stockdale A, Flynn BS: Interviews with primary care physicians regarding taking and interpreting the cancer family history. Fam Pract. 2008, 25: 334-340.
- International Cancer Screening Network. Inventory of Colorectal Cancer Screening Activities in ICSN Countries, May 2008. Retrieved Jun 3, 2016 from http://healthcaredelivery.cancer.gov/icsn/colorectal/screening.html
- Glaser B, Strauss A. The Discovery of Grounded Theory. Chicago, IL: Aldine, 1967.
- J Leddin Desmond , Robert Enns, ,Robert Hilsden, Victor Plourde, Linda Rabeneck, et al. Canadian Association of Gastroenterology position statement on screening individuals at average risk for developing colorectal cancer: 2010. Can J Gastroenterol. 2010 Dec; 24(12): 705–714.
- Australian government. National bowel cancer. Retrieved Jun 3, 2016 from http://www.cancerscreening.gov.au/internet/screening/publishing.nsf/content/bowel-campaign-home
- American gastroenterology association. Guidelines. Retrieved Jun 15, 2015 from http://www.gastro.org/guidelines
- Chen S, Wang W, Lee S, et al. Prediction of germline mutations and cancer risk in the Lynch syndrome. JAMA. 2006;296(12):1479–87.
- Brain K, Soldan J, Sampson J, Gray J. Genetic counselling protocols for hereditary non-polyposis colorectal cancer: a survey of UK regional genetics centres. Clin Genet. 2003 Mar;63(3):198-204.
- Goulard H1, Boussac-Zarebska M, Ancelle-Park R, Bloch J.French colorectal cancer screening pilot programme: results of the first round. J Med Screen. 2008;15(3):143-8.
- Whitlock EP, Lin JS, Liles E, Beil TL, Fu R. Screening for colorectal cancer: a targeted, updated systematic review for the U.S. Preventive Services Task Force. Ann Intern Med. 2008 Nov 4;149(9):638-58.
- Weller DP, Campbell C. Weller DP, Campbell C. Uptake in cancer screening programmes: a priority in cancer control. Br J Cancer 2009;101(Suppl 2):S55–9.
- AbouHaidar Gladys N Honein, Monika Kastner, Vincent Vuong, Laure Perrier, Linda Rabeneck. Benefits and barriers to participation in colorectal cancer screening: a protocol for a systematic review and synthesis of qualitative studies BMJ Open 2014;4(2).
- Kaminski MF, Regula J, Kraszewska E, Polkowski M, Wojciechowska U, et al: Quality indicators for colonoscopy and the risk of interval cancer. N Engl J Med 2010; 362(19):1795–1803.
- WesslingErin Jenkins, Stephen J. Colonoscopy and chromoscopy in hereditary colorectal cancer syndromes. 2016 July; 15(3): 453-455.
- Riemann J.F. Schröder C. Kallenbach M. Giersiepen K. Schmoll H.-J. Benefits and Risks of Colorectal Cancer Screening. Oncol Res Treat 2014;37(suppl 3):11-20.
- European Colorectal Cancer Screening Guidelines Working Group. European guidelines for quality assurance in colorectal cancer screening and diagnosis: Overview and introduction to the full Supplement publication. Endoscopy. 2013; 45(1): 51–59.
- Abstract Viewed: 644 times
- PDF Downloaded: 162 times